Diffúz nagy B-sejtes limfóma (DLBCL): vizsgálatok itt: Kína
133 trials · From ClinicalTrials.gov, checked 2026. november 16.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleLenalidomide Combined With G-CHOP in the Treatment of Newly Diagnosed DLBCL With FL
- Where
- Xiamen
- Életkor
- 18 év to 70 év
- People
- 38
- Run by
- The First Affiliated Hospital of Xiamen University
See details and how to joinNCT06151080 - 2. fázisTaking peopleAZA Combined With RCHOP in P53-mutated DLBCL.
- Where
- Xiamen
- Életkor
- 18 év to 70 év
- People
- 52
- Run by
- The First Affiliated Hospital of Xiamen University
See details and how to joinNCT06158399 - No phaseTaking peopleA Multicenter, Prospective, Real-world Study of a Regimen Containing Tucidinostat for Primary Treatment of DLBCL
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 400
- Run by
- Ruijin Hospital
See details and how to joinNCT06779435 - No phaseTaking peopleRituximab-Methotrexate-Temozolomide-Thiotepa (RMTT) Regimen As First-line Therapy for PCNS DLBCL
- Where
- Hangzhou
- Életkor
- 18 év to 75 év
- People
- 44
- Run by
- Zhejiang Cancer Hospital
See details and how to joinNCT06832267 - 1. fázisTaking peopleSequential Treatment of CD19 CARNK and 7x19 CAR-T in R/R B Cell Lymphoma
- Where
- Hangzhou
- Életkor
- 18 év to 75 év
- People
- 52
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT06464861 - 2. fázisNot yet taking people in KínaAZA Combined with R-GemOx for Elderly DLBCL Patients
- Where
- Chongqing
- Életkor
- 60 év to 90 év
- People
- 80
- Run by
- Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
See details and how to joinNCT06778902 - No phaseTaking peoplePET Imaging Targeting Granzyme B Predicts Immunotherapy Efficacy in Diffuse Large B-cell Lymphoma
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 150
- Run by
- Ruijin Hospital
See details and how to joinNCT06755775 - 2. fázisTaking peopleCR-CHOP+X in Previously Untreated DEL
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 49
- Run by
- Ruijin Hospital
See details and how to joinNCT06701357 - 2. fázisNot yet taking people in KínaCD-RCHOP in ND DLBCL With a Combination of TP53 Mutation and Del(17p)
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 34
- Run by
- Ruijin Hospital
See details and how to joinNCT06750991 - No phaseTaking peopleReal-World Study of DLBCL With Different Genetic Subtypes
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 10 000
- Run by
- Ruijin Hospital
See details and how to joinNCT06026488 - 1/2. fázisTaking peopleA Prospective Clinical Study of the Combination Therapy of Obutinib or Decitabine with Rituximab, Cyclophosphamide, and Prednisone for the Primary Treatment of Elderly Patients with Newly Diagnosed Diffuse Large B-cell Lymphoma
- Where
- Zhengzhou
- Életkor
- 65 év and over
- People
- 80
- Run by
- Mingzhi Zhang
See details and how to joinNCT06683885 - No phaseNot yet taking people in KínaThe Effectiveness and Safety of Glofitamab in Real-World Clinical Practice Among Chinese Adult Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Prospective, Observational, Multicenter Study
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 200
- Run by
- Ruijin Hospital
See details and how to joinNCT06656234 - 2. fázisTaking peopleOrelabrutinib in Combination with R-CHOP for CD5-positive DLBCL Patients(Rocket Trial)
- Where
- Dongguan, Guangzhou, Lanzhou, Shantou, Shenzhen, Zhaoqing, Zhuhai
- Életkor
- 18 év and over
- People
- 39
- Run by
- Sun Yat-sen University
See details and how to joinNCT06647940 - 2. fázisNot yet taking people in KínaHigh-dose Methotrexate Combined with Thiotepa and Zanubrutinib in the Treatment of Newly Diagnosed PCNSL (MTZ)
- Where
- Guangzhou
- Életkor
- 18 év to 70 év
- People
- 30
- Run by
- Sun Yat-sen University
See details and how to joinNCT06646211 - 2. fázisTaking peopleZanubrutinib and Lenalidomide as Maintenance Therapy in DLBCL
- Where
- Beijing
- Életkor
- 14 év and over
- People
- 240
- Run by
- Navy General Hospital, Beijing
See details and how to joinNCT06503263 - 2. fázisNot yet taking people in KínaMolecular Subtype-Guided R-CHOP-MTX±Zanubrutinib Treatment in Newly Diagnosed DLBCL Patients with Central Nervous System Involvement
- Where
- Nanjing
- Életkor
- 18 év to 80 év
- People
- 40
- Run by
- The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT06594432 - 1. fázisTaking peoplePhase I Clinical Trial of RC19D2 Cell Injection in the Treatment of Diffuse Large B-cell Lymphoma
- Where
- Tianjin
- Életkor
- 18 év and over
- People
- 25
- Run by
- Beijing Yongtai Ruike Biotechnology Company Ltd
See details and how to joinNCT06047197 - 2. fázisTaking peopleA Study of Trilaciclib Combined With Chemotherapy in the Treatment of Diffuse Large B-Cell Lymphoma Patients
- Where
- Guangzhou
- Életkor
- 18 év and over
- People
- 38
- Run by
- Sun Yat-sen University
See details and how to joinNCT06569485 - 2. fázisTaking peopleA Study of Zanubrutinib in Combination With Polatuzumab Vedotin, Bendamustine and Rituximab in the Treatment of Relapsed/Refractory Diffuse Large B-cell Lymphoma
- Where
- Hanzhou
- Életkor
- 18 év to 75 év
- People
- 36
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT06554600 - 3. fázisTaking peopleThe Efficacy and Safety of Pola-ZR2 Versus ZR2 in the Treatment of Old Patients With de Novo Diffuse Large B-cell Lymphoma
- Where
- Shanghai
- Életkor
- 70 év and over
- People
- 100
- Run by
- Ruijin Hospital
See details and how to joinNCT06522555 - 2. fázisTaking peopleMilaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study
- Where
- Hangzhou
- Életkor
- 18 év to 65 év
- People
- 260
- Run by
- Zhejiang Provincial People's Hospital
See details and how to joinNCT06534762 - 3. fázisTaking peopleEvaluate the Safety and Efficacy of Tafasitamab and Lenalidomide in Combination With Gemcitabine and Oxaliplatin Versus Rituximab in Combination With Gemcitabine and Oxaliplatin in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
- Where
- Beijing, Changchun, Changsha, Chaozhou, Chengdu, Chongqing, Guangzhou, Hangzhou, Jinan, Nanchang, Nanjing, Shanghai, Suzhou, Tianjin, Ürümqi, Wenzhou, Wuhan, Zhengzhou
- Életkor
- 18 év and over
- People
- 244
- Run by
- Beijing InnoCare Pharma Tech Co., Ltd.
See details and how to joinNCT06521255 - 1. fázisTaking peopleAn Open-label, Single-arm Study of JWCAR201 in the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 9
- Run by
- Fudan University
See details and how to joinNCT06517004 - No phaseNot yet taking people in KínaPlasma cfDNA Testing Guiding the Treatment Decisions of DLBCL
- Where
- Suzhou
- Életkor
- 18 év and over
- People
- 30
- Run by
- Second Affiliated Hospital of Soochow University
See details and how to joinNCT06289959 - 2. fázisTaking peoplePola-R2 in Newly Diagnosed Non-fit Elderly DLBCL Patients
- Where
- Beijing
- Életkor
- 70 év and over
- People
- 30
- Run by
- Yan Zhang, MD
See details and how to joinNCT06176729